JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

A more recent version of this article appeared on November 12, 2004 Originally published In Press as doi:10.1074/jbc.M405311200 on September 1, 2004
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
279/46/48004    most recent
M405311200v2
M405311200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grabiec, A.
Right arrow Articles by Kirschning, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grabiec, A.
Right arrow Articles by Kirschning, C. J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print September 13, 2004
J. Biol. Chem, 10.1074/jbc.M405311200
Submitted on May 12, 2004
Revised on August 26, 2004
Accepted on September 1, 2004

Human but not murine toll-like receptor 2 discriminates between tri-palmitoylated and tri-lauroylated peptides

Alina Grabiec, Guangxun Meng, Sylvia Fichte, Wolfgang Bessler, Hermann Wagner, and Carsten J. Kirschning

Institute of Medical Microbiology, Immunology, and Hygiene, Technical University of Munich, Munich, Bavaria 81675

Corresponding Author: carsten.kirschning{at}lrz.tum.de

Toll-like receptors (TLRs) mediate activation of the immune system upon challenge with microbial agonists, components of disintegrating cells of the body, or metabolic intermediates of lipidic nature. Comparison of murine (m) and human (h) TLR2 primary sequences revealed 65% of identical residues within the extracellular domains in contrast to 84% in the intracellular domains. Comparative analysis of TLR2-driven cell activation by various TLR2 agonists showed that the tri-lauroylated lipopeptide analogue (Lau3CSK4) is recognized efficiently through mTLR2 but not hTLR2. Genetically complemented human embryonic kidney (HEK) 293 cells and murine TLR2-/- embryonic fibroblasts, as well as human and murine macrophage cells were used for this analysis. In contra st to cellular activation, which depended on blockable access of the TLR2-ligand to TLR2, cellular uptake of Lau3CSK4 and tri-palmitoylated peptide (P3CSK4) was independent of TLR2. A low-conserved region spanning from leucine rich repeat (LRR) motif 7 to 10 was found to control TLR2 species-specific cell activation. Exchange of mLRR8 for hLRR8 in mTLR2 abrogated mTLR2-typical cell activation upon cellular challenge with Lau3CSK4 but not P3CSK4 implicating mLRR8 as a central element of Lau3CSK4 recognitio n. The point mutation L112P within LRR3 abrogated hTLR2-dependent recognition of lipopeptides but merely attenuated mTLR2 function, while deletion of the N-terminal third of each LRR-rich domain (LRRs 1 to 7) had the opposite effect on P3CSK4 recognition. Despite similar domain structure of both TLR2 molecules, species-specific properties thus exist. Our results imply distinct susceptibilities of humans and mice to challenge with specific TLR2 ligands.›


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. P. Mizgerd and S. J. Skerrett
Animal models of human pneumonia
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L387 - L398.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
S. Onishi, K. Honma, S. Liang, P. Stathopoulou, D. Kinane, G. Hajishengallis, and A. Sharma
Toll-Like Receptor 2-Mediated Interleukin-8 Expression in Gingival Epithelial Cells by the Tannerella forsythia Leucine-Rich Repeat Protein BspA
Infect. Immun., January 1, 2008; 76(1): 198 - 205.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
T. A. Rupprecht, C. J. Kirschning, B. Popp, S. Kastenbauer, V. Fingerle, H.-W. Pfister, and U. Koedel
Borrelia garinii Induces CXCL13 Production in Human Monocytes through Toll-Like Receptor 2
Infect. Immun., September 1, 2007; 75(9): 4351 - 4356.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. D. Harzenetter, A. R. Novotny, P. Gais, C. A. Molina, F. Altmayr, and B. Holzmann
Negative Regulation of TLR Responses by the Neuropeptide CGRP Is Mediated by the Transcriptional Repressor ICER
J. Immunol., July 1, 2007; 179(1): 607 - 615.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. M. Keestra, M. R. de Zoete, R. A. M. H. van Aubel, and J. P. M. van Putten
The Central Leucine-Rich Repeat Region of Chicken TLR16 Dictates Unique Ligand Specificity and Species-Specific Interaction with TLR2
J. Immunol., June 1, 2007; 178(11): 7110 - 7119.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Merx, M. Neumaier, H. Wagner, C. J Kirschning, and P. Ahmad-Nejad
Characterization and investigation of single nucleotide polymorphisms and a novel TLR2 mutation in the human TLR2 gene
Hum. Mol. Genet., May 15, 2007; 16(10): 1225 - 1232.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Spiller, S. Dreher, G. Meng, A. Grabiec, W. Thomas, T. Hartung, K. Pfeffer, H. Hochrein, H. Brade, W. Bessler, et al.
Cellular Recognition of Trimyristoylated Peptide or Enterobacterial Lipopolysaccharide via Both TLR2 and TLR4
J. Biol. Chem., May 4, 2007; 282(18): 13190 - 13198.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
E. Andersen-Nissen, K. D. Smith, R. Bonneau, R. K. Strong, and A. Aderem
A conserved surface on Toll-like receptor 5 recognizes bacterial flagellin
J. Exp. Med., February 19, 2007; 204(2): 393 - 403.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. Buwitt-Beckmann, H. Heine, K.-H. Wiesmuller, G. Jung, R. Brock, S. Akira, and A. J. Ulmer
TLR1- and TLR6-independent Recognition of Bacterial Lipopeptides
J. Biol. Chem., April 7, 2006; 281(14): 9049 - 9057.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Chen, P. Iribarren, J. Hu, J. Chen, W. Gong, E. H. Cho, S. Lockett, N. M. Dunlop, and J. M. Wang
Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid beta Peptide
J. Biol. Chem., February 10, 2006; 281(6): 3651 - 3659.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. O. Omueti, J. M. Beyer, C. M. Johnson, E. A. Lyle, and R. I. Tapping
Domain Exchange between Human Toll-like Receptors 1 and 6 Reveals a Region Required for Lipopeptide Discrimination
J. Biol. Chem., November 4, 2005; 280(44): 36616 - 36625.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. P. Wang, E. A. Kurt-Jones, O. S. Shin, M. D. Manchak, M. J. Levin, and R. W. Finberg
Varicella-Zoster Virus Activates Inflammatory Cytokines in Human Monocytes and Macrophages via Toll-Like Receptor 2
J. Virol., October 15, 2005; 79(20): 12658 - 12666.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
E Cario
BACTERIAL INTERACTIONS WITH CELLS OF THE INTESTINAL MUCOSA: TOLL-LIKE RECEPTORS AND NOD2
Gut, August 1, 2005; 54(8): 1182 - 1193.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.